Lombard Odier Asset Management Switzerland Sa Upped Nordstrom (JWN) Holding By $417,266; Broadfin Capital Has Raised Mirati Therapeutics (MRTX) Holding By $1.20 Million

October 13, 2017 - By Michael Collier

Broadfin Capital Llc increased Mirati Therapeutics Inc (MRTX) stake by 19.13% reported in 2017Q2 SEC filing. Broadfin Capital Llc acquired 400,000 shares as Mirati Therapeutics Inc (MRTX)’s stock declined 41.13%. The Broadfin Capital Llc holds 2.49M shares with $9.09 million value, up from 2.09M last quarter. Mirati Therapeutics Inc now has $353.32 million valuation. The stock increased 1.77% or $0.25 during the last trading session, reaching $14.4. About 407,109 shares traded. Mirati Therapeutics, Inc. (NASDAQ:MRTX) has declined 76.51% since October 13, 2016 and is downtrending. It has underperformed by 93.21% the S&P500.

Lombard Odier Asset Management Switzerland Sa increased Nordstrom Inc (JWN) stake by 46.47% reported in 2017Q2 SEC filing. Lombard Odier Asset Management Switzerland Sa acquired 8,878 shares as Nordstrom Inc (JWN)’s stock declined 10.77%. The Lombard Odier Asset Management Switzerland Sa holds 27,984 shares with $1.34 million value, up from 19,106 last quarter. Nordstrom Inc now has $7.09 billion valuation. The stock increased 0.14% or $0.06 during the last trading session, reaching $42.65. About 1.42 million shares traded. Nordstrom, Inc. (NYSE:JWN) has risen 9.86% since October 13, 2016 and is uptrending. It has underperformed by 6.84% the S&P500.

Among 29 analysts covering Nordstrom Inc. (NYSE:JWN), 8 have Buy rating, 6 Sell and 15 Hold. Therefore 28% are positive. Nordstrom Inc. had 90 analyst reports since August 14, 2015 according to SRatingsIntel. The stock of Nordstrom, Inc. (NYSE:JWN) earned “Hold” rating by Deutsche Bank on Monday, October 31. The rating was downgraded by Citigroup to “Neutral” on Tuesday, January 5. The firm has “Buy” rating by Cowen & Co given on Friday, June 9. The rating was upgraded by Northcoast on Monday, May 16 to “Neutral”. Nomura maintained the stock with “Hold” rating in Monday, May 15 report. The company was maintained on Monday, February 27 by RBC Capital Markets. Guggenheim initiated the stock with “Buy” rating in Tuesday, November 10 report. The stock of Nordstrom, Inc. (NYSE:JWN) earned “Hold” rating by RBC Capital Markets on Tuesday, October 3. The firm earned “Buy” rating on Friday, February 19 by Topeka Capital Markets. The stock has “Buy” rating by Maxim Group on Friday, November 11.

Lombard Odier Asset Management Switzerland Sa decreased Halozyme Therapeutics Inc (NASDAQ:HALO) stake by 161,225 shares to 138,775 valued at $1.78 million in 2017Q2. It also reduced Alphabet Inc stake by 9,000 shares and now owns 4,262 shares. Nuvasive Inc (NASDAQ:NUVA) was reduced too.

Investors sentiment decreased to 0.84 in 2017 Q2. Its down 0.03, from 0.87 in 2017Q1. It dived, as 59 investors sold JWN shares while 179 reduced holdings. 72 funds opened positions while 128 raised stakes. 92.48 million shares or 1.86% less from 94.23 million shares in 2017Q1 were reported. Logan Cap accumulated 0.16% or 45,542 shares. Rhumbline Advisers holds 226,067 shares. Ftb Incorporated invested in 853 shares. Webster Savings Bank N A holds 450 shares. Price T Rowe Associates Md, a Maryland-based fund reported 197,114 shares. Sandy Spring Financial Bank reported 0.01% in Nordstrom, Inc. (NYSE:JWN). Employees Retirement Association Of Colorado reported 0.01% of its portfolio in Nordstrom, Inc. (NYSE:JWN). Mason Street Advsrs Ltd Limited Liability Company stated it has 15,441 shares. Ameritas Invest Prtnrs holds 2,778 shares. Aristotle stated it has 23,133 shares or 0.01% of all its holdings. Bessemer Gp, a New Jersey-based fund reported 1,000 shares. Shamrock Asset Management Limited Liability Company holds 308 shares. Northern Tru owns 1.60 million shares. 11,100 were reported by Old Mutual Glob (Uk) Ltd. Pacad Inv Limited stated it has 34,700 shares or 0.24% of all its holdings.

Broadfin Capital Llc decreased Endo Intl Plc (NASDAQ:ENDP) stake by 753,077 shares to 1.25 million valued at $13.93 million in 2017Q2. It also reduced Aralez Pharmaceuticals Inc stake by 3.16 million shares and now owns 2.03 million shares. Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) was reduced too.

Among 10 analysts covering Mirati Therapeutics (NASDAQ:MRTX), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Mirati Therapeutics had 24 analyst reports since September 17, 2015 according to SRatingsIntel. The stock of Mirati Therapeutics, Inc. (NASDAQ:MRTX) has “Outperform” rating given on Tuesday, May 24 by Wedbush. Leerink Swann maintained it with “Market Perform” rating and $9 target in Friday, September 15 report. Barclays Capital maintained the stock with “Overweight” rating in Monday, June 6 report. H.C. Wainwright reinitiated the stock with “Buy” rating in Thursday, October 12 report. The firm earned “Hold” rating on Monday, July 17 by Jefferies. Wedbush maintained the shares of MRTX in report on Monday, June 6 with “Outperform” rating. As per Wednesday, January 13, the company rating was upgraded by Citigroup. The stock of Mirati Therapeutics, Inc. (NASDAQ:MRTX) has “Mkt Perform” rating given on Monday, June 6 by Leerink Swann. The firm has “Buy” rating by Jefferies given on Thursday, March 10. Jefferies maintained Mirati Therapeutics, Inc. (NASDAQ:MRTX) on Friday, August 4 with “Hold” rating.

Investors sentiment decreased to 0.68 in 2017 Q2. Its down 1.26, from 1.94 in 2017Q1. It fall, as 19 investors sold MRTX shares while 15 reduced holdings. 12 funds opened positions while 11 raised stakes. 11.06 million shares or 8.92% less from 12.14 million shares in 2017Q1 were reported. Goldman Sachs Incorporated owns 0% invested in Mirati Therapeutics, Inc. (NASDAQ:MRTX) for 98,251 shares. Broadfin Cap Limited Liability Com holds 2.49M shares or 1.1% of its portfolio. Hikari Power Limited holds 0.05% of its portfolio in Mirati Therapeutics, Inc. (NASDAQ:MRTX) for 100,000 shares. Credit Suisse Ag stated it has 0% in Mirati Therapeutics, Inc. (NASDAQ:MRTX). State Street Corporation accumulated 13,517 shares. Moreover, Alyeska Invest Grp Ltd Partnership has 0.01% invested in Mirati Therapeutics, Inc. (NASDAQ:MRTX). Parallax Volatility Advisers LP has 1,600 shares. Bnp Paribas Arbitrage Sa has 2 shares for 0% of their portfolio. Millennium Management Ltd has invested 0% of its portfolio in Mirati Therapeutics, Inc. (NASDAQ:MRTX). Lmr Llp accumulated 64,760 shares. Macquarie Group Inc Limited stated it has 80,000 shares. Hillhouse Management Ltd holds 0.04% of its portfolio in Mirati Therapeutics, Inc. (NASDAQ:MRTX) for 725,000 shares. Element Cap Limited invested in 0.08% or 107,222 shares. Paloma Prns Management has invested 0% in Mirati Therapeutics, Inc. (NASDAQ:MRTX). Baker Bros Limited Partnership has 0.07% invested in Mirati Therapeutics, Inc. (NASDAQ:MRTX).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com